Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 13 to 21

Using Exparel to control pain after MPFL reconstruction in kids

Official title: Prospective Evaluation of Post-operative Pain Management Using Exparel in the Pediatric Population

Run by Texas Scottish Rite Hospital for Children · NCT06559215 · Data updated 2026-11-12

This study sees if adding Exparel to standard local anesthesia reduces post-op pain and opioid pill use in patients aged 13 and older having an isolated MPFL reconstruction.

Quick facts

PhasePhase 2
Study typeInterventional
Ages13 Years to 21 Years
SexAll
Enrollment100 (estimated)
SponsorTexas Scottish Rite Hospital for Children
Academic / other
Locations1 site (Frisco, Texas)
StatusRecruiting
StartedDecember 1, 2025
Main results expectedSeptember 2027
Study endsSeptember 2028
Registry record updatedMarch 9, 2026
Trial IDNCT06559215 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients aged 13 years or older scheduled for an isolated MPFL reconstruction who can provide assent and whose guardian can give consent.

Probably not a fit

Patients younger than 13, those requiring additional procedures (fracture repair, arthrotomy, tibial tubercle osteotomy, or other non-isolated lower-extremity surgery), pregnant patients, those with BMI ≥ 40, or anyone with prior hypersensitivity to Exparel/local anesthetics are excluded and unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-institution, single-blinded randomized controlled trial will enroll 100 pediatric patients (minimum 80 completers) undergoing isolated MPFL reconstruction and randomize them to receive Exparel plus Marcaine versus Marcaine-only local infiltration. Patients and families will provide assent/consent and patient-reported pain outcomes will be collected using VAS scores and an institution pain questionnaire on postoperative days 1, 4, and 7. Narcotic consumption (number of pills taken) and a pain management satisfaction survey at day 7 are secondary outcomes, with demographic and surgical data pulled from the electronic medical record. The trial is conducted at Texas Scottish Rite Hospital for Children (Frisco, TX) and is single-blinded to the patient.

Why it matters

Potential benefit: If successful, this approach could lower short-term pain and reduce opioid pill use after MPFL reconstruction in adolescents.

How similar studies have gone: Adult studies of liposomal bupivacaine (Exparel) have shown modest reductions in pain and opioid use for some procedures, but pediatric evidence is limited and results have been mixed.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Must be aged 13+ years at time of surgery
* Must present with injury requiring an isolated MPFL Reconstruction
* Ability to provide assent, legally appointed representative available to provide informed consent

Exclusion Criteria:

* Patient \<13 years old
* Requires fracture repair or another non-standardized surgery
* Any MPFL Reconstruction that requires the use of arthrotomy or a tibial tubercle osteotomy
* Any lower extremity procedure that is not an isolated MPFL Reconstruction
* Patient pregnancy
* Inability to provide assent or legally appointed representative to provide informed consent
* Prior history of hypersensitivity to Exparel or any local anesthesia
* BMI ≥ 40

Where it's running

  • Texas Scottish Rite Hospital for Children
    Frisco, Texas, United States
    Recruiting

Study contacts

  • Principal investigator: Philip Wilson, MD — Texas Scottish Rite Hospital for Children
  • Study coordinator: Robert Van Pelt, MPH
  • Email: bobby.vanpelt@tsrh.org
  • Phone: 2145597456

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.